RHAPSIDO
Live / Registered — Cancelled — Section 71 (as of 12 Dec 2025)
What this means for you
Registered since 28 May 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79247188
- Registration number
- 5760082
- Mark type
- Stylized text
- Filed
- 26 Sept 2018
- Published for opposition
- 12 Mar 2019
- Registered
- 28 May 2019
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
Owner
- Novartis AG, CH
- Novartis AG, CH
- Novartis AG, CH
Prosecution history
- 12 Dec 2025 — CANCELLED SECTION 71
- 28 May 2024 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 24 Feb 2022 — INTERNATIONAL REGISTRATION RENEWED
- 27 Sept 2019 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 12 Sept 2019 — FINAL DISPOSITION NOTICE SENT TO IB
- 12 Sept 2019 — FINAL DISPOSITION PROCESSED
- 28 Aug 2019 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 28 May 2019 — REGISTERED-PRINCIPAL REGISTER
- 12 Mar 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 12 Mar 2019 — PUBLISHED FOR OPPOSITION
- 08 Mar 2019 — NOTIFICATION PROCESSED BY IB
- 20 Feb 2019 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 20 Feb 2019 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 20 Feb 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 05 Feb 2019 — LAW OFFICE PUBLICATION REVIEW COMPLETED